Distribution of Biospecimens From Biorepositories/Biobanks for Research Use

NCT03884400 | Withdrawn

• 1 other identifier: ISPC-180828-DISTRIBUTION
• Study Type: observational
• Target: N/A
• Locations: 1 country
• Sites: 1

Brief Summary

This protocol seeks to assist biorepositories/biobanks in distributing their stored specimens and data to researchers that will actually utilize them to advance medicine and technology.

Conditions

Cancer; Pregnancy Related; Gastro-Intestinal Disorder; Cardio-Respiratory Distress; Women's Health: Endometriosis; Autoimmune Diseases; Nephritis; Healthy; Neuro-Degenerative Disease

Keywords

Observational

Outcome Measures

Primary Outcomes (1)

• Distribution of Biospecimens From Biorepositories/Biobanks for Research Use

  The number of specimens and subjects distributed per disease will be measured and reported.

  15 years

Study Arms (1)

Subjects who have provided consent for specimen collection

Re-consent will not be required. This protocol allows distribution of the specimens following the terms agreed to by the subject in the original consent.

Procedure: Specimens obtained from surgical, phlebotomy or other non-invasive procedure

Interventions

Specimens obtained from surgical, phlebotomy or other non-invasive procedure PROCEDURE

Biospecimen Collection

Subjects who have provided consent for specimen collection

Eligibility Criteria

• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Child (0-17), Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

Diverse group of biorepositories with focus on cancer, neurodegenerative, pediatric, women's health and other cohorts.

You may qualify if:

• Specimens and/or data from Biorepositories that have enrolled subjects that have provided consent for the specimens and de-identified data to be collected, stored and distributed.
• Specimens from biobanks that have collected materials and de-identified data under a waiver of consent
• Specimens from a biobank that meet the criteria for non human subject research under the common rule.

You may not qualify if:

• Specimens and/or that have been obtained from subjects without informed consent, nor waiver of consent or that do not meet the criteria for non human subject research under the common rule.

Sponsors & Collaborators

• iSpecimen Inc: lead

Study Sites (1)

iSpecimen

Lexington, Massachusetts, 02420, United States

Location

Related Links

• Website for specimen distribution

MeSH Terms

Conditions

Neoplasms; Digestive System Diseases; Autoimmune Diseases; Nephritis

Interventions

Phlebotomy

Condition Hierarchy (Ancestors)

Immune System Diseases; Kidney Diseases; Urologic Diseases; Female Urogenital Diseases; Female Urogenital Diseases and Pregnancy Complications; Urogenital Diseases; Male Urogenital Diseases

Intervention Hierarchy (Ancestors)

Blood Specimen Collection; Specimen Handling; Clinical Laboratory Techniques; Diagnostic Techniques and Procedures; Diagnosis; Punctures; Therapeutics; Surgical Procedures, Operative; Investigative Techniques

Study Design

• Study Type: observational
• Observational Model: OTHER
• Time Perspective: CROSS SECTIONAL
• Sponsor Type: INDUSTRY
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: March 18, 2019
• First Posted: March 21, 2019
• Study Start: January 1, 2021
• Primary Completion: December 31, 2025
• Study Completion: March 1, 2026
• Last Updated: November 14, 2022

Record last verified: 2022-11

Data Sharing

• IPD Sharing: Will not share

Locations

US (1)